Core Laboratories Earnings Estimate

CLB Stock  USD 15.23  0.53  3.61%   
The next projected EPS of Core Laboratories is estimated to be 0.1533 with future projections ranging from a low of 0.14 to a high of 0.17. Core Laboratories' most recent 12-month trailing earnings per share (EPS TTM) is at 0.66. Please be aware that the consensus of earnings estimates for Core Laboratories NV is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Core Laboratories is projected to generate 0.1533 in earnings per share on the 31st of March 2025. Core Laboratories earnings estimates show analyst consensus about projected Core Laboratories NV EPS (Earning Per Share). It derives the highest and the lowest estimates based on Core Laboratories' historical volatility. Many public companies, such as Core Laboratories, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Core Laboratories Revenue Breakdown by Earning Segment

By analyzing Core Laboratories' earnings estimates, investors can diagnose different trends across Core Laboratories' analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit is expected to grow to about 168.6 M. The current year's Pretax Profit Margin is expected to grow to 0.11
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Core Laboratories Earnings Estimation Breakdown

The calculation of Core Laboratories' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Core Laboratories is estimated to be 0.1533 with the future projection ranging from a low of 0.14 to a high of 0.17. Please be aware that this consensus of annual earnings estimates for Core Laboratories NV is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.22
0.14
Lowest
Expected EPS
0.1533
0.17
Highest

Core Laboratories Earnings Projection Consensus

Suppose the current estimates of Core Laboratories' value are higher than the current market price of the Core Laboratories stock. In this case, investors may conclude that Core Laboratories is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Core Laboratories' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
692.67%
0.22
0.1533
0.66

Core Laboratories Earnings History

Earnings estimate consensus by Core Laboratories analysts from Wall Street is used by the market to judge Core Laboratories' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Core Laboratories' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Core Laboratories Quarterly Gross Profit

129.24 Million

At present, Core Laboratories' Retained Earnings are projected to decrease significantly based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 37.27, whereas Retained Earnings Total Equity is forecasted to decline to about 73.5 M. As of March 17, 2025, Common Stock Shares Outstanding is expected to decline to about 40.7 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 21.3 M.
Hype
Prediction
LowEstimatedHigh
12.2815.1918.10
Details
Intrinsic
Valuation
LowRealHigh
14.8117.7220.63
Details
Naive
Forecast
LowNextHigh
12.1815.1018.01
Details
6 Analysts
Consensus
LowTargetHigh
17.5919.3321.46
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Core assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Core Laboratories. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Core Laboratories' stock price in the short term.

Core Laboratories Earnings per Share Projection vs Actual

Actual Earning per Share of Core Laboratories refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Core Laboratories NV predict the company's earnings will be in the future. The higher the earnings per share of Core Laboratories, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Core Laboratories Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Core Laboratories, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Core Laboratories should always be considered in relation to other companies to make a more educated investment decision.

Core Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Core Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-01-30
2024-12-310.220.220.0
2024-10-24
2024-09-300.2340.250.016
2024-07-24
2024-06-300.210.220.01
2024-04-24
2024-03-310.160.190.0318 
2024-01-31
2023-12-310.190.190.0
2023-11-01
2023-09-300.220.220.0
2023-07-26
2023-06-300.20.210.01
2023-04-26
2023-03-310.160.190.0318 
2023-02-01
2022-12-310.20.20.0
2022-10-26
2022-09-300.150.180.0320 
2022-07-27
2022-06-300.140.12-0.0214 
2022-04-27
2022-03-310.090.08-0.0111 
2022-02-02
2021-12-310.20.20.0
2021-10-27
2021-09-300.190.18-0.01
2021-07-28
2021-06-300.190.18-0.01
2021-04-21
2021-03-310.130.150.0215 
2021-01-27
2020-12-310.150.180.0320 
2020-10-21
2020-09-300.150.160.01
2020-07-22
2020-06-300.10.140.0440 
2020-04-22
2020-03-310.340.31-0.03
2020-01-29
2019-12-310.370.380.01
2019-10-23
2019-09-300.490.50.01
2019-07-24
2019-06-300.460.460.0
2019-04-24
2019-03-310.430.440.01
2019-01-30
2018-12-310.490.48-0.01
2018-10-24
2018-09-300.630.640.01
2018-07-25
2018-06-300.590.590.0
2018-04-25
2018-03-310.570.570.0
2018-01-31
2017-12-310.580.580.0
2017-10-23
2017-09-300.440.480.04
2017-07-24
2017-06-300.510.520.01
2017-04-19
2017-03-310.390.420.03
2017-01-25
2016-12-310.40.410.01
2016-10-19
2016-09-300.380.380.0
2016-07-20
2016-06-300.350.350.0
2016-04-20
2016-03-310.370.370.0
2016-01-27
2015-12-310.650.650.0
2015-10-21
2015-09-300.830.830.0
2015-07-22
2015-06-300.770.820.05
2015-04-22
2015-03-310.850.860.01
2015-01-28
2014-12-311.541.540.0
2014-10-22
2014-09-301.521.530.01
2014-07-23
2014-06-301.341.350.01
2014-04-23
2014-03-311.451.450.0
2014-01-29
2013-12-311.411.430.02
2013-10-16
2013-09-301.341.360.02
2013-07-17
2013-06-301.321.320.0
2013-04-17
2013-03-311.151.220.07
2013-01-30
2012-12-311.131.170.04
2012-10-17
2012-09-301.111.130.02
2012-07-18
2012-06-301.151.160.01
2012-04-18
2012-03-311.061.060.0
2012-02-01
2011-12-311.081.090.01
2011-10-19
2011-09-300.991.00.01
2011-07-20
2011-06-300.880.90.02
2011-04-19
2011-03-310.750.770.02
2011-02-09
2010-12-310.810.810.0
2010-10-20
2010-09-300.780.790.01
2010-07-21
2010-06-300.720.750.03
2010-04-28
2010-03-310.660.690.03
2010-02-10
2009-12-310.60.630.03
2009-10-22
2009-09-300.560.570.01
2009-07-22
2009-06-300.620.620.0
2009-04-22
2009-03-310.650.660.01
2009-02-11
2008-12-310.820.880.06
2008-10-22
2008-09-300.790.820.03
2008-07-23
2008-06-300.740.760.02
2008-04-23
2008-03-310.680.690.01
2008-02-13
2007-12-310.670.680.01
2007-10-24
2007-09-300.630.650.02
2007-07-25
2007-06-300.580.590.01
2007-04-23
2007-03-310.490.520.03
2007-02-14
2006-12-310.470.490.02
2006-10-25
2006-09-300.390.420.03
2006-07-26
2006-06-300.30.350.0516 
2006-04-26
2006-03-310.250.290.0416 
2006-02-15
2005-12-310.250.280.0312 
2005-10-26
2005-09-300.210.240.0314 
2005-07-27
2005-06-300.170.190.0211 
2005-04-27
2005-03-310.140.160.0214 
2005-02-23
2004-12-310.160.170.01
2004-10-28
2004-09-300.140.140.0
2004-07-28
2004-06-300.120.120.0
2004-04-28
2004-03-310.080.10.0225 
2004-02-25
2003-12-310.120.120.0
2003-10-29
2003-09-300.10.10.0
2003-07-30
2003-06-300.060.080.0233 
2003-05-09
2003-03-310.050.04-0.0120 
2003-02-28
2002-12-310.090.05-0.0444 
2002-10-24
2002-09-300.080.080.0
2002-07-29
2002-06-300.060.060.0
2002-05-07
2002-03-310.060.05-0.0116 
2002-02-21
2001-12-310.10.10.0
2001-10-25
2001-09-300.140.140.0
2001-07-25
2001-06-300.110.130.0218 
2001-04-26
2001-03-310.090.090.0
2001-02-27
2000-12-310.110.110.0
2000-10-30
2000-09-300.090.090.0
2000-07-28
2000-06-300.060.070.0116 
2000-04-28
2000-03-310.060.05-0.0116 
2000-02-10
1999-12-310.120.120.0
1999-10-29
1999-09-300.090.090.0
1999-07-30
1999-06-300.050.050.0
1999-04-30
1999-03-310.010.020.01100 
1999-03-25
1998-12-310.140.09-0.0535 
1998-10-27
1998-09-300.130.140.01
1998-07-30
1998-06-300.10.120.0220 
1998-04-23
1998-03-310.080.090.0112 
1998-02-26
1997-12-310.110.120.01
1997-10-22
1997-09-300.080.10.0225 
1997-08-14
1997-06-300.070.080.0114 
1997-04-25
1997-03-310.050.050.0
1997-02-26
1996-12-310.060.060.0
1996-10-25
1996-09-300.060.060.0

About Core Laboratories Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Core Laboratories earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Core Laboratories estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Core Laboratories fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings150.3 M193.2 M
Retained Earnings Total Equity77.4 M73.5 M
Earnings Yield 0.04  0.03 
Price Earnings Ratio 26.29  37.27 
Price Earnings To Growth Ratio(1.60)(1.52)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.896
Dividend Share
0.04
Earnings Share
0.66
Revenue Per Share
11.17
Quarterly Revenue Growth
0.008
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.